Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    IRLAB Therapeutics

    MCap

    SEK653m

    Last close

    SEK14.10

    ▲ 1.50 (11.90%)

    VolitionRx

    MCap

    USD51m

    Last close

    USD0.60

    ▲ 0.05 (9.82%)

    Portobello SpA

    MCap

    EUR12m

    Last close

    EUR2.38

    ▲ 0.20 (9.17%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

The Biotech Growth Trust in 60 seconds

The Biotech Growth Trust in 60 seconds

The Biotech Growth Trust — 1 video in collection

More on this equity

Edison’s investment companies team recently published a review of The Biotech Growth Trust (BIOG). The trust’s managers Geoff Hsu and Josh Golomb at leading global healthcare specialist OrbiMed are positive on the outlook for biotech stocks. Higher interest rates have pressured the sector’s valuation despite a favourable fundamental industry backdrop, which includes a high level of innovation, elevated new drug approvals and robust merger and acquisition activity ahead of a major patent cliff. BIOG has a structural bias towards smaller-cap biotech companies, which has been beneficial over the long term but detrimental during the recent industry sell off. The managers are expecting history to repeat, with small-cap biotech stocks leading an industry recovery, which may be amplified by a reduction in US interest rates.

< Previous
Next >

You may also be interested in these:

Investment Companies

JPMorgan European Discovery Trust in 60 seconds

Investment Companies

Baillie Gifford US Growth Trust in 60 seconds

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free